Procter & Gamble Health Ltd. (IN:PGHL)
:PGHL
Want to see IN:PGHL full AI Analyst Report?
Total Valuation
Procter & Gamble Health Ltd. has a market cap or net worth of ₹104.14B. The enterprise value is ₹98.77B.
Market Cap₹104.14B
Enterprise Value₹98.77B
Share Statistics
Procter & Gamble Health Ltd. has 16,599,382 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,599,382
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Procter & Gamble Health Ltd.’s return on equity (ROE) is 0.62 and return on invested capital (ROIC) is 53.34%.
Return on Equity (ROE)0.62
Return on Assets (ROA)0.39
Return on Invested Capital (ROIC)53.34%
Return on Capital Employed (ROCE)0.74
Revenue Per Employee10.54M
Profits Per Employee3.37M
Employee Count1,336
Asset Turnover1.67
Inventory Turnover4.47
Valuation Ratios
The current PE Ratio of Procter & Gamble Health Ltd. is 31.9. Procter & Gamble Health Ltd.’s PEG ratio is 0.81.
PE Ratio31.9
PS Ratio5.67
PB Ratio15.22
Price to Fair Value15.22
Price to FCF24.77
Price to Operating Cash Flow47.13
PEG Ratio0.81
Income Statement
In the last 12 months, Procter & Gamble Health Ltd. had revenue of 14.08B and earned 3.27B in profits. Earnings per share was 196.94.
Revenue14.08B
Gross Profit7.97B
Operating Income4.33B
Pretax Income4.50B
Net Income3.27B
EBITDA4.74B
Earnings Per Share (EPS)196.94
Cash Flow
In the last 12 months, operating cash flow was 2.21B and capital expenditures -92.20M, giving a free cash flow of 2.12B billion.
Operating Cash Flow2.21B
Free Cash Flow2.12B
Free Cash Flow per Share127.85
Dividends & Yields
Procter & Gamble Health Ltd. pays an annual dividend of ₹160, resulting in a dividend yield of 3.28%
Dividend Per Share₹160
Dividend Yield3.28%
Payout Ratio67.63%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.49
52-Week Price Change6.95%
50-Day Moving Average5.39K
200-Day Moving Average5.64K
Relative Strength Index (RSI)71.68
Average Volume (3m)310.00
Important Dates
Procter & Gamble Health Ltd. upcoming earnings date is Nov 11, 2026, TBA (Confirmed).
Last Earnings DateMay 26, 2026
Next Earnings DateNov 11, 2026
Ex-Dividend Date―
Financial Position
Procter & Gamble Health Ltd. as a current ratio of 2.18, with Debt / Equity ratio of 1.77%
Current Ratio2.18
Quick Ratio1.65
Debt to Market Cap0.00
Net Debt to EBITDA-0.37
Interest Coverage Ratio787.40
Taxes
In the past 12 months, Procter & Gamble Health Ltd. has paid 1.23B in taxes.
Income Tax1.23B
Effective Tax Rate0.27
Enterprise Valuation
Procter & Gamble Health Ltd. EV to EBITDA ratio is 16.47, with an EV/FCF ratio of 24.22.
EV to Sales5.54
EV to EBITDA16.47
EV to Free Cash Flow24.22
EV to Operating Cash Flow23.11
Balance Sheet
Procter & Gamble Health Ltd. has ₹2.86B in cash and marketable securities with ₹95.50M in debt, giving a net cash position of ₹2.77B billion.
Cash & Marketable Securities₹2.86B
Total Debt₹95.50M
Net Cash₹2.77B
Net Cash Per Share₹166.64
Tangible Book Value Per Share₹316.01
Margins
Gross margin is 65.00%, with operating margin of 30.76%, and net profit margin of 23.22%.
Gross Margin65.00%
Operating Margin30.76%
Pretax Margin31.95%
Net Profit Margin23.22%
EBITDA Margin33.67%
EBIT Margin31.99%
Analyst Forecast
The average price target for Procter & Gamble Health Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast13.04%
EPS Growth Forecast4.60%